Final Programme - iuphar

FC09 Inflammation and immunopharmacology:
New tools for old diseases
Tue 219 Lipopolysaccharide induced changes of liver function in μ-opioid-receptor-wildtype and -knockout mice
Amelie Lupp, (Germany), S Schulz
Tue 220 Cerebral ischemia induces micro vascular pro-inflammatory cytokine expression via the MEK/ERK
pathway
Aida Maddahi, (Sweden), L Edvinsson
Tue 221 Pharmacological evaluation of clinically active compounds in a model of cystic fibrosis related
inflammation
Rangan Maitra, (USA), A Giddings, J Tajuba
Tue 222 Malnutrition and biomarkers of inflamation in elderly patients
Eva Mala, (Czech Republic), E Buresova, J Novosad, I Krcmova, J Krejsek, M Pliskova, L Sobotka,
I Urbanova
Tue 223 Clavulanic acid reduces neutrophil infiltration and oedema response in carrageenan-induced acute
inflammation
Nasrin Maleki-Dizaji, (Iran), A Banani, A Garjani, H Hamishehkar, A Fakhrjou
Tue 224 Association of genetic polymorphisms of eNOS and iNOS with immune sensitization in asthmatic
children
Vangelis G Manolopoulos, (Greece), M Iordanidou, A Tavridou, E Paraskakis, A Chatzimichael
Tue 225 Paradoxical influences of mTOR inhibitor everolimus on progressive renal failure
Satohiro Masuda, (Japan), S Nakagawa, K Nishihara, K Inui
Tue 226 Effect of valsartan on bone loss in periodontal disease induced by lipopolysaccharides in the rat
Maria Gabriela Matos, (Venezuela), L Perdomo, M Alvarez, M Varela, A Stern, M del Rosario Garrido
Tue 227 Inhibitor of apoptosis proteins (IAPs) as novel targets in inflammatory processes of endothelial cells
Bettina Mayer, (Germany), C Reichel, F Krombach, S Zahler, A Vollmar, R Fürst
Tue 228 Administration of edoxaban, an oral factor Xa inhibitor, is safe in healthy subjects post warfarin
treatment- encore abstract
Jeanne Mendell, (USA), R Noveck, I Rubets, M Shi
Tue 229 A novel mechanism for neutrophil trapping in endotoxemic hepatic microvasculature: Downregulation of
β-2 integrin via IL-10
Gustavo Menezes, (Brazil), W-Y Lee, H Zhou, C Waterhouse, D Cara, P Kubes
Tue 230 Agonist-mediated changes in intracellular calcium in human bronchial epithelial cells
P Menon, K Varanou, Ian McFadzean, (UK)
Tue 231 The enhancement of pentylenetetrazole-induced seizure threshold in mice via cyclooxygenase-2
inhibition by nimesulide
Azam Mesdaghinia, (Iran), A Heydari, P Khazaee, H Yazdanpanah
Tue 232 Cannabinoid receptor activation inhibits smooth muscle cell proliferation and endothelial cytokine
production
Lisa Michel, (UK), K Skene, S Teixeira, E Hector, H Vosper, C Wainwright
Tue 233 Expression of 5-HT receptors by human immune cells: Impact of physiological activation
Sarah Milton, (UK), A Butler, J Curnow, J Gordon, N Barnes
Tue 234 Aqueous cigarette tar extract causes marked bronchial smooth muscle hyperresponsiveness in rats
Miwa Misawa, (Japan), A Watanabe, A Fujita, H Sakai, J Kamei, Y Chiba
Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area 217